Miguel Abboud to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Miguel Abboud has written about Randomized Controlled Trials as Topic.
Connection Strength
0.260
-
Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Cochrane Database Syst Rev. 2020 04 06; 4:CD012389.
Score: 0.126
-
Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Cochrane Database Syst Rev. 2017 05 13; 5:CD012389.
Score: 0.103
-
Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3). Contemp Clin Trials. 2019 10; 85:105835.
Score: 0.030